257 related articles for article (PubMed ID: 36327313)
41. The development of a fluorescence/colorimetric biosensor based on the cleavage activity of CRISPR-Cas12a for the detection of non-nucleic acid targets.
Wang Y; Peng Y; Li S; Han D; Ren S; Qin K; Zhou H; Han T; Gao Z
J Hazard Mater; 2023 May; 449():131044. PubMed ID: 36821893
[TBL] [Abstract][Full Text] [Related]
42. Programmable Aptasensor for Regulating CRISPR/Cas12a Activity.
Yu Y; Li Q; Shi W; Yang Y; He H; Dai J; Mao G; Ma Y
ACS Sens; 2024 Jan; 9(1):244-250. PubMed ID: 38085648
[TBL] [Abstract][Full Text] [Related]
43. DNA Robots for CRISPR/Cas12a Activity Management and Universal Platforms for Biosensing.
Xia X; Chen Q; Zuo T; Liang Z; Xu G; Wei F; Yang J; Hu Q; Zhao Z; Tang BZ; Cen Y
Anal Chem; 2024 Feb; 96(6):2620-2627. PubMed ID: 38217497
[TBL] [Abstract][Full Text] [Related]
44. Synergistic Incorporation of Two ssDNA Activators Enhances the Trans-Cleavage of CRISPR/Cas12a.
Li Q; Song ZL; Zhang Y; Zhu L; Yang Q; Liu X; Sun X; Chen X; Kong R; Fan GC; Luo X
Anal Chem; 2023 Jun; 95(23):8879-8888. PubMed ID: 37252785
[TBL] [Abstract][Full Text] [Related]
45. Label-free dual-mode sensing platform based on target-regulated CRISPR-Cas12a activity for ochratoxin A in
Xu H; Pan R; Huang W; Zhu X
Anal Methods; 2023 Sep; 15(35):4518-4523. PubMed ID: 37622284
[TBL] [Abstract][Full Text] [Related]
46. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
[TBL] [Abstract][Full Text] [Related]
47. A novel "signal on-off-super on" sandwich-type aptamer sensor of CRISPR-Cas12a coupled voltage enrichment assay for VEGF detection.
Yuan G; Xia X; Zhang J; Huang J; Xie F; Li X; Chen D; Peng C
Biosens Bioelectron; 2023 Feb; 221():114424. PubMed ID: 35691789
[TBL] [Abstract][Full Text] [Related]
48. A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets.
Li CY; Zheng B; Liu YH; Gao JL; Zheng MQ; Pang DW; Tang HW
Biosens Bioelectron; 2020 Dec; 169():112650. PubMed ID: 32987327
[TBL] [Abstract][Full Text] [Related]
49. Programmable CRISPR-Cas12a and self-recruiting crRNA assisted dual biosensing platform for simultaneous detection of lung cancer biomarkers hOGG1 and FEN1.
Cheng X; Xia X; Ren D; Chen Q; Xu G; Wei F; Yang J; Wang L; Hu Q; Zou J; Cen Y
Anal Chim Acta; 2023 Feb; 1240():340748. PubMed ID: 36641157
[TBL] [Abstract][Full Text] [Related]
50. A programmable and sensitive CRISPR/Cas12a-based MicroRNA detection platform combined with hybridization chain reaction.
Jia HY; Zhao HL; Wang T; Chen PR; Yin BC; Ye BC
Biosens Bioelectron; 2022 Sep; 211():114382. PubMed ID: 35605545
[TBL] [Abstract][Full Text] [Related]
51. Ultrasensitive Point-of-Care Detection of Protein Markers Using an Aptamer-CRISPR/Cas12a-Regulated Liquid Crystal Sensor (ALICS).
Qi L; Liu J; Liu S; Liu Y; Xiao Y; Zhang Z; Zhou W; Jiang Y; Fang X
Anal Chem; 2024 Jan; 96(2):866-875. PubMed ID: 38164718
[TBL] [Abstract][Full Text] [Related]
52. Cascade DNA Circuits Mediated CRISPR-Cas12a Fluorescent Aptasensor based on Multifunctional Fe
Lv Y; Sun Y; Zhou Y; Khan IM; Niazi S; Yue L; Zhang Y; Wang Z
Small; 2023 Apr; 19(16):e2206105. PubMed ID: 36683240
[TBL] [Abstract][Full Text] [Related]
53. Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.
Dai Y; Somoza RA; Wang L; Welter JF; Li Y; Caplan AI; Liu CC
Angew Chem Int Ed Engl; 2019 Nov; 58(48):17399-17405. PubMed ID: 31568601
[TBL] [Abstract][Full Text] [Related]
54. Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotides.
Cui C; Lau CH; Chu LT; Kwong HK; Tin C; Chen TH
Biosens Bioelectron; 2023 Jan; 220():114859. PubMed ID: 36368142
[TBL] [Abstract][Full Text] [Related]
55. An optimized microRNA detection platform based on PAM formation-regulated CRISPR/Cas12a activation.
Li D; Liang P; Ling S; Wu Y; Lv B
Int J Biol Macromol; 2024 May; 266(Pt 1):130848. PubMed ID: 38521316
[TBL] [Abstract][Full Text] [Related]
56. Direct and noninvasive fluorescence analysis of an RNA-protein interaction based on a CRISPR/Cas12a-powered assay.
Wang X; Jing S; Wang W; Wang J
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Oct; 299():122884. PubMed ID: 37210856
[TBL] [Abstract][Full Text] [Related]
57. CRISPR/Cas-Assisted Nanoneedle Sensor for Adenosine Triphosphate Detection in Living Cells.
Kim H; Gu C; Mustfa SA; Martella DA; Wang C; Wang Y; Chiappini C
ACS Appl Mater Interfaces; 2023 Nov; 15(43):49964-49973. PubMed ID: 37769296
[TBL] [Abstract][Full Text] [Related]
58. A novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1.
Wu Z; Sun DW; Pu H; Wei Q
Talanta; 2023 Jan; 252():123773. PubMed ID: 36081307
[TBL] [Abstract][Full Text] [Related]
59. CRISPR/Cas12a linked sandwich aptamer assay for sensitive detection of thrombin.
Zhu F; Zhao Q
Anal Chim Acta; 2024 Jan; 1287():342106. PubMed ID: 38182384
[TBL] [Abstract][Full Text] [Related]
60. Photoactivatable CRISPR/Cas12a Sensors for Biomarkers Imaging and Point-of-Care Diagnostics.
Li QN; Wang DX; Chen DY; Lyu JA; Wang YX; Wu SL; Jiang HX; Kong DM
Anal Chem; 2024 Feb; 96(6):2692-2701. PubMed ID: 38305871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
